Melanotan I (MT-1) 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Melanotan I supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF082025007

Key analytical results include:

• Assay Content: 9.83 mg
• Identification – Retention Time: 0.996
• Identification – Spectrum: 993
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Melanotan I is a synthetic peptide research compound frequently studied in controlled laboratory environments investigating melanocortin receptor signalling and pigmentation-related biochemical pathways.

The compound belongs to a class of melanocortin receptor agonists derived from the naturally occurring hormone alpha-melanocyte-stimulating hormone (α-MSH).

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Melanotan I has become a compound referenced in experimental research models studying melanocortin signalling systems.

Compound Overview

Melanotan I is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide involved in pigmentation and melanocortin receptor signalling.

The compound is primarily investigated in biochemical research exploring melanocortin receptor activation, particularly interactions with melanocortin receptor subtype MC1R.

Within experimental laboratory environments, Melanotan I is often examined in models studying receptor-mediated signalling pathways, peptide hormone interactions and pigmentation-related biochemical regulation.

These research systems allow scientists to investigate melanocortin receptor signalling networks and their influence on cellular regulatory pathways.

Historical Background and Scientific Context

Scientific investigation into melanocortin signalling systems expanded significantly during the late twentieth century as peptide hormone research advanced.

Researchers studying alpha-melanocyte-stimulating hormone began exploring synthetic peptide analogues capable of interacting with melanocortin receptors in controlled laboratory settings.

During the 1990s and early 2000s, Melanotan I emerged as one of the early experimental peptide analogues designed to interact with melanocortin receptors involved in pigmentation-related biological pathways.

Since then, the compound has been studied in a variety of experimental research models investigating melanocortin receptor signalling and peptide-mediated cellular communication.

Mechanistic Focus in Research

Within experimental laboratory settings, Melanotan I is often studied in relation to melanocortin receptor activation and peptide-mediated signalling pathways.

Research investigations commonly explore the compound in experimental models examining:

• Melanocortin receptor interaction pathways
• MC1R receptor activation dynamics
• Peptide hormone signalling systems
• Pigmentation-related biochemical pathways
• Comparative melanocortin agonist research
• Cellular receptor signalling networks
• Peptide-mediated intracellular regulatory processes

These experimental models allow scientists to investigate molecular signalling mechanisms involved in melanocortin receptor systems.

Research Applications

In controlled research environments, Melanotan I may be utilised in experimental models designed to explore melanocortin receptor signalling and peptide hormone regulatory pathways.

Examples of research applications include:

• Melanocortin receptor signalling research
• Peptide hormone interaction studies
• Pigmentation pathway investigation
• Cell signalling analysis
• Comparative receptor agonist evaluation
• Biochemical peptide research
• Controlled in vitro receptor signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF082025007 – Published September 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.